COVID-Related Section 301 Product Exclusions
- Home
- Federal Agencies
- US Trade Representative - USTR
- COVID-Related Section 301 Product Exclusions
RILA strongly urges the Administration to extend the Section 301 tariff exclusions for medical-care products that are essential for keeping Americans safe. COVID-19 remains unpredictable, and the pandemic illustrates the importance of public health preparedness. Limiting barriers to these critical products will prevent America from being caught flat-footed by the evolving nature of COVID-19 and other viruses and ensure the U.S. is better prepared for future public health crises.
Latest on International Trade

Press Release
Penny Crisis: Main Street Businesses Call for SNAP Clarity
- By [Austen Jensen]
- 10/14/2025
Press Release
Main Street Businesses Urge Swift Congressional Action to Prevent Penny Crisis
- By [Austen Jensen]
- 10/01/2025

Blog Post
Why Supply Chain Executives Should Rethink Internal Systems
- By [Jess Dankert]
- 10/01/2025
Press Release
RLC Welcomes Josh Moore as Vice President of Litigation
- By [Monica Welt]
- 09/29/2025

Press Release
RILA Adds USTR Veteran to Government Affairs Team
- By [Evan Armstrong]
- 09/24/2025
Blog Post
Harnessing AI for Precision Forecasting in Retail
- By [Jess Dankert]
- 09/17/2025

Blog Post
AI Legislation Across the U.S.: A 2025 End of Session Recap
- By [Austin Gold, Townsend Brown]
- 09/08/2025
Press Release
Retailers urge Fed nominee to highlight debit rule revision
- 09/04/2025

Blog Post
What happens to Trump’s IEEPA tariffs if he loses in court
- By [Ellen Jackson]
- 09/03/2025
Regulatory Comment Letter
CPSC RFI: Reducing Regulatory Burdens
- 08/11/2025

Blog Post
Unlocking Strategic Supply Chain Connections
- By [Jess Dankert]
- 08/11/2025
Press Release
Retail Leaders Applaud Temporary Fed Nominee Stephen Miran
- By [Austen Jensen]
- 08/07/2025